Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ATXS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ATXS investment potential.

What is ATXS stock price today?

Get real-time ATXS stock price, historical data, and price charts on Financhill. Track ATXS performance with our advanced analysis tools.

Is ATXS a good investment?

Evaluate ATXS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ATXS stock?

To buy ATXS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ATXS?

View detailed market capitalization data and company valuation metrics for ATXS on our comprehensive analysis page.

What is the P/E ratio of ATXS?

Use our fundamental analysis tools to view ATXS P/E ratio and compare valuation metrics with industry peers.

What are ATXS earnings?

View ATXS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Astria Therapeutics, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

ATXS
Astria Therapeutics, Inc.

Last Price:

$13.12

Seasonality Move:

28.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Astria Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Astria Therapeutics, Inc. has on average historically fallen by 13.6% based on the past 10 years of stock performance.
Astria Therapeutics, Inc. has fallen lower in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Astria Therapeutics, Inc. Stock Undervalued?

The current Astria Therapeutics, Inc. [ATXS] share price is $13.12. The Score for ATXS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
ATXS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Astria Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Astria Therapeutics, Inc. has on average historically fallen by 13.6% based on the past 10 years of stock performance.

Astria Therapeutics, Inc. Stock Rating

Sell

Astria Therapeutics, Inc. (ATXS) is a Sell

Is Astria Therapeutics, Inc. overpriced?

Astria Therapeutics, Inc. has fallen lower in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Astria Therapeutics, Inc. Stock Price History

Is ATXS stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATXS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

astriatx.com

52-Week Data

52-Week High:

13.29

52-Week Low:

3.56

Prediction Charts

Market Cap:

749M

Price in USD:

13.12

Volume:

2.8M

Beta:

1.10

Technical Analysis

SMA50:

11.22

SMA100:

9.03

SMA200:

7.22

52-Wk Change:

29.39%

Stock Predictions

Is Astria Therapeutics, Inc. stock public?

Yes, Astria Therapeutics, Inc. is a publicly traded company.
What is the Astria Therapeutics, Inc. stock quote today?

The Astria Therapeutics, Inc. stock price is 13.12 USD today.
How to buy Astria Therapeutics, Inc. stock online?

You can buy Astria Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	12.31	12.57	12.59	12.29
Nov-17	12.47	12.57	12.62	12.43
Nov-18	12.53	12.49	12.57	12.47
Nov-19	12.49	12.44	12.52	12.31
Nov-20	12.55	12.45	12.56	12.37
Nov-21	12.43	12.51	12.57	12.40
Nov-24	12.55	12.35	12.56	12.29
Nov-25	12.41	12.34	12.46	12.30
Nov-26	12.37	12.60	12.64	12.31
Nov-28	12.65	12.65	12.69	12.61
Dec-1	12.64	12.62	12.66	12.55
Dec-2	12.64	12.60	12.72	12.59
Dec-3	12.66	13.09	13.10	12.63
Dec-4	13.09	13.12	13.29	13.06

Astria Therapeutics, Inc. Earnings

Astria Therapeutics, Inc. Earnings Report: Per Share Astria Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Astria Therapeutics, Inc. Forecast Revenue Growth

Astria Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Astria Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and a decrease next year of $0.23 per share.

* Astria Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.